Abnormal behavior and neurotransmissions of tenascin gene knockout mouse

Biochemical and Biophysical Research Communications

Volumn 221, Issue 1, 1996, Pages 151-156

  Fukamauchi, Fumihiko ^a,b   Mataga, Nobuko ^a   Wang, Yi Jun ^a   Sato, Shigeo ^b   Yoshiki, Atsushi ^b   Kusakabe, Moriaki ^b  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b RIKEN TSUKUBA INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 IODO 2,5 DIMETHOXYAMPHETAMINE; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; NEUROTRANSMITTER; QUINPIROLE; SEROTONIN; SEROTONIN AGONIST; TENASCIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; BRAIN CORTEX; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC ACTIVITY; GENE DISRUPTION; HIPPOCAMPUS; LOCOMOTION; MOUSE; MOUSE MUTANT; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; SWIMMING;

EID: 0029867714     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1996.0561     Document Type: Article

References (15)

1. Erickson, H. P., and Bourdon, M. A. (1989) Ann. Rev. Cell. Biol. 5, 71-92.
2. End, P., Panayotou, G., Entwistle, A., Waterfield, M. D., and Chiquet, M. (1992) Eur. J. Biochem. 209, 1041-1051.
3. Husmann, K., Faissner, A., and Schachner, M. (1992) J. Cell. Biol. 116, 1475-1486.
4. Steindler, D. A., Settles, D., Erickson, H. P., Laywell, E. D., Yoshiki, A., Faissner, A., and Kusakabe, M. (1995) J. Neurosci. 15, 1971-1983.
5. Saga, Y., Yagi, T., Ikawa, Y., Sakakura, T., and Aizawa, S. (1992) Genes Dev. 6, 1821-1831.
6. Mataga, N., Imamura, K., and Watanabe, Y. (1991) Brain Res. 551, 64-71.
7. Leysen, J. E., Niemegeers, C. J. E., Van Nueten, J. M., and Laduron, P. M. (1982) Mol. Pharmacol. 21, 301-314.
8. Seeman, P., Ulpian, C., Wreggett, K. A., and Wells, J. W. (1984) J. Neurochem. 43, 221-235.
9. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. (1951) J. Biol. Chem. 193, 265-275.
10. Jones, M. W., Kilpatrick, I. C., and Phillipson, O. T. (1986) Neurosci. Lett. 72, 330-334.
11. Coppen, A. J., and Doogan, D. P. (1988) J. Clin. Psychiat. 49, 4-11.
12. Goodwin, G. M., and Green, A. R. (1985) Br. J. Pharmacol. 84, 734-753.
13. Seeman, P. (1992) Neuropsychopharmacology 7, 261-284.
14. Ben-Zeev, A. (1986) Trends Biochem. Sci. 11, 478-481.
15. Bissell, M. J., Hall, H. G., and Parry, G. (1982) J. Theor. Biol. 99, 31-68.